McDeFa completes B-round financing of more than RMB 100 million, helping global low-carbon environmental protection and human medical health

▤ Summary

McDeFa completed a B-round financing of more than RMB 100 million. The company develops fully bio-based, biodegradable PHA biomaterials and related downstream products. It plans to use the new capital to advance strain R&D, improve production lines, lower costs, expand application scenarios, and grow global markets. The company also reported progress in medical device registration, bringing its PHA materials closer to clinical use.

$ Funding

▦ Linked Companies